S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Wall Street rises to more records to close out its latest winning month
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
3 Value Stocks Too Small For Buffett’s Portfolio
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
OTCMKTS:GTHP

Guided Therapeutics (GTHP) Stock Price, News & Analysis

$0.12
0.00 (-0.86%)
(As of 05:45 PM ET)
Today's Range
$0.11
$0.13
50-Day Range
$0.12
$0.19
52-Week Range
$0.06
$0.30
Volume
134,415 shs
Average Volume
30,869 shs
Market Capitalization
$6.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GTHP stock logo

About Guided Therapeutics Stock (OTCMKTS:GTHP)

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. It focuses on the commercialization of LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorporated in 1992 and is based in Norcross, Georgia.

GTHP Stock Price History

GTHP Stock News Headlines

How you can target big results without spending big money!
While most folks are paying $500… $1,000… Or even MORE to trade popular stocks like Apple, Nvidia, or Microsoft… I’ve discovered a new way to tap into what could be the cheapest options on the market… I’m talking about the $0.25 Cent Trades!
Guided Therapeutics Inc
GTHP
Urgent: Protect Your Investments from a Chinese Invasion
An alarming new reality is unfolding across America. The United States is bracing for the unthinkable - a potential Chinese invasion.
See More Headlines
Receive GTHP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guided Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/28/2024
Next Earnings (Estimated)
5/13/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Current Symbol
OTCMKTS:GTHP
Employees
6
Year Founded
N/A

Profitability

Net Income
$-4,340,000.00
Pretax Margin
-7,437.88%

Debt

Sales & Book Value

Annual Sales
$10,000.00
Book Value
($0.12) per share

Miscellaneous

Free Float
18,245,000
Market Cap
$6.41 million
Optionable
Not Optionable
Beta
0.35
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Key Executives

  • Dr. Mark L. Faupel Ph.D. (Age 69)
    CEO, President, COO, Acting CFO, Secretary & Director
    Comp: $46.91k

GTHP Stock Analysis - Frequently Asked Questions

How have GTHP shares performed in 2024?

Guided Therapeutics' stock was trading at $0.1535 at the beginning of the year. Since then, GTHP stock has decreased by 24.1% and is now trading at $0.1165.
View the best growth stocks for 2024 here
.

Are investors shorting Guided Therapeutics?

Guided Therapeutics saw a increase in short interest in the month of February. As of February 29th, there was short interest totaling 6,400 shares, an increase of 392.3% from the February 14th total of 1,300 shares. Based on an average trading volume of 70,700 shares, the days-to-cover ratio is presently 0.1 days.
View Guided Therapeutics' Short Interest
.

When is Guided Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 13th 2024.
View our GTHP earnings forecast
.

How do I buy shares of Guided Therapeutics?

Shares of GTHP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GTHP) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners